Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03848663 · ClinicalTrials.gov registry record · NA
Visual Remapping to Aid Reading With Field Loss
A NA study of Age-related Macular Degeneration, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT03848663 is a NA study of Age-related Macular Degeneration that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 108 participants, below the 1,506-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03848663, a NA study of Age-related Macular Degeneration, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
Reading performance in patients with Central Vision Loss and age matched controls with artificial scotomas will be measured with and without different kinds of remapping of missing text to different parts of the visual field.
Conditions Studied
Interventions
- BEHAVIORAL Traditional Remapping
- BEHAVIORAL Personalized Remapping
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03848663
The ClinicalTrials.gov registry entry for NCT03848663 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,506-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (93% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 2 interventions - of which Traditional Remapping is the first listed.
NCT03848663 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03848663 about?
NCT03848663 is a clinical study titled "Visual Remapping to Aid Reading With Field Loss". Reading performance in patients with Central Vision Loss and age matched controls with artificial scotomas will be measured with and without different kinds of remapping of missing text to different parts of the visual field.
What is the current status of trial NCT03848663?
This trial is currently recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2022-02-01. Estimated completion is 2026-07-01.
What conditions does trial NCT03848663 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration.
What interventions are being tested in trial NCT03848663?
The interventions under investigation include: Traditional Remapping (BEHAVIORAL), Personalized Remapping (BEHAVIORAL).
Who is sponsoring clinical trial NCT03848663?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03848663 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
-
Lutein, Zeaxathin, and Fish Oil Supplementation
RECRUITING · NA
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
-
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
RECRUITING · NA
-
AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.